SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
85.20    1.20 (1.43%)
Bid:
85.20
Ask:
85.90
Spread: 0.70 (0.822%)
Market Cap: £238.73m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Director/PDMR Shareholding

4 Apr 2023 08:49

RNS Number : 3020V
Essentra plc
04 April 2023
Β 

Essentra plc (the "Company")

Director/PDMR Holding

The notification below, is made on behalf of PDMRs under article 19.1 of the Market Abuse Regulation ('MAR') and in accordance with Article 19.3 of MAR.

On 31 March 2023, the Company made grants of performance shares under the Long-Term Incentive Plan to Group Executive Committee members who are PDMRs of Essentra plc.

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Sam Edwards

Gabriele Hannen

Hugues Delcourt

Robert Baker

Lynne Vandeveer

Emma Reid

Β 

2

Β 

Reason for the notification

Β 

a)

Position/status

Β 

Sam Edwards Chief Digital Information Officer

Gabriele Hannen Chief Strategy Officer

Hugues Delcourt Chief Sales Officer and Director, EMEARobert Baker Chief Operating Officer

Lynne Vandeveer Chief Marketing Officer and President, AmericasEmma Reid Company Secretary

Β 

b)

Β 

Initial notification /Amendment

Initial

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Essentra plc

b)

Β 

LEI

Β 

5493007MOZNA03BVNE96

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Ordinary 25p shares

Identification code

GB00B0744359

b)

Β 

Nature of the transaction

Β 

Β 

Award of performance shares under the Essentra plc Long-Term Incentive Plan Part B. The shares are deferred for three years subject to the attainment of performance conditions.

Β 

c)

Price(s) and volume(s)

Name

Price (Β£)

Volume

Sam Edwards

1.9580

71,629

Gabriele Hannen

1.9580

97,077

Hugues Delcourt

1.9580

93,025

Robert Baker

1.9580

75,970

Lynne Vandeveer

1.9580

116,602

Emma Reid

1.9580

65,1177

d)

Aggregated information

- Aggregrated volume

Β 

- Price

Β 

518,420

Β 

Β£1.9580

Β 

e)

Β 

Date of the transaction

Β 

31 March 2023

f)

Β 

Place of the transaction

London Stock Exchange

Β 

Β 

For further enquiries, please contact:

Essentra plc

Emma Reid, Company Secretary

Tel: +44 (0)1908 359100

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUPUBCCUPWUMC
Date   Source Headline
10th Jun 20269:47 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:32 pmRNSTransaction in Own Shares
21st May 202610:55 amRNSResult of AGM
20th May 20267:00 amRNSAcquisition of Boteco Srl
20th May 20267:00 amRNS2026 AGM Trading Update
14th May 20265:15 pmRNSDirector/PDMR Shareholding
12th May 20267:03 amRNSTransaction in Own Shares
1st May 202612:17 pmRNSTotal Voting Rights
29th Apr 20268:12 amRNSTransaction in Own Shares
28th Apr 20263:25 pmRNSDirector/PDMR Shareholding
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20268:15 amRNSTransaction in Own Shares
21st Apr 20264:09 pmRNSDirector/PDMR Shareholding
17th Apr 20267:52 amRNSHolding(s) in Company
15th Apr 202610:06 amRNSDirector/PDMR Shareholding
15th Apr 20268:24 amRNSTransaction in Own Shares
15th Apr 20268:18 amRNSHolding(s) in Company
9th Apr 20268:24 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:45 pmRNSDirector/PDMR Shareholding
1st Apr 20263:21 pmRNSDirector/PDMR Shareholding
1st Apr 20263:15 pmRNSTransaction in Own Shares
1st Apr 20263:08 pmRNSTotal Voting Rights
30th Mar 20262:00 pmRNSAnnual Financial Report
24th Mar 202610:05 amRNSTransaction in Own Shares
24th Mar 20268:17 amRNSHolding(s) in Company
19th Mar 20268:43 amRNSDirector/PDMR Shareholding
17th Mar 20261:41 pmRNSDirector/PDMR Shareholding
17th Mar 202610:30 amRNSDirectorate change
17th Mar 202610:28 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
16th Mar 20269:40 amRNSTransaction in Own Shares
16th Mar 20269:40 amRNSTransaction in Own Shares
13th Mar 202612:00 pmRNSCompany Secretary Change
9th Mar 20269:00 amRNSNotice of Full Year 2025 Results
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:58 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202612:20 pmRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.